{"id":"https://openalex.org/W9566688","doi":"https://doi.org/10.1096/fasebj.25.1_supplement.1004.7","title":"Mechanisms underlying the neuroprotective effects of fisetin and ibuprofen in the MPTP model of Parkinson's disease","display_name":"Mechanisms underlying the neuroprotective effects of fisetin and ibuprofen in the MPTP model of Parkinson's disease","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W9566688","doi":"https://doi.org/10.1096/fasebj.25.1_supplement.1004.7","mag":"9566688"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.25.1_supplement.1004.7","doi":"https://doi.org/10.1096/fasebj.25.1_supplement.1004.7","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.25.1_supplement.1004.7","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W9566688"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007995485","display_name":"Mital Y. Patel","orcid":"https://orcid.org/0000-0002-9975-3146","observed_orcids":["https://orcid.org/0000-0002-9975-3146"]},"institutions":[{"id":"https://openalex.org/I138873065","display_name":"Long Island University","ror":"https://ror.org/0324fzh77","country_code":"US","type":"education","lineage":["https://openalex.org/I138873065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mital Yogeshbhai Patel","raw_affiliation_strings":["Pharmaceutical Sciences Arnold & Marie Schwartz College of Pharmacy Long Island University Brooklyn NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences Arnold & Marie Schwartz College of Pharmacy Long Island University Brooklyn NY","institution_ids":["https://openalex.org/I138873065"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005149616","display_name":"Kenza E. Benzeroual","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138873065","display_name":"Long Island University","ror":"https://ror.org/0324fzh77","country_code":"US","type":"education","lineage":["https://openalex.org/I138873065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenza E. Benzeroual","raw_affiliation_strings":["Pharmaceutical Sciences Arnold & Marie Schwartz College of Pharmacy Long Island University Brooklyn NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences Arnold & Marie Schwartz College of Pharmacy Long Island University Brooklyn NY","institution_ids":["https://openalex.org/I138873065"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I138873065"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0010317,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"25","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9290000200271606},{"id":"https://openalex.org/keywords/mptp","display_name":"MPTP","score":0.8650000095367432},{"id":"https://openalex.org/keywords/fisetin","display_name":"fisetin","score":0.8159999847412109},{"id":"https://openalex.org/keywords/ibuprofen","display_name":"ibuprofen","score":1.0},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9890000224113464},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.984000027179718},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.972000002861023},{"id":"https://openalex.org/keywords/pc12-cells","display_name":"PC12 cells","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9549999833106995},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.968999981880188},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":1.0},{"id":"https://openalex.org/keywords/mitochondrial-complex-i-inhibition","display_name":"mitochondrial complex I inhibition","score":0.8220000267028809},{"id":"https://openalex.org/keywords/mitochondrial-dysfunction","display_name":"mitochondrial dysfunction","score":0.5120000243186951},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.9335658550262451},{"id":"https://openalex.org/C2777376040","wikidata":"https://www.wikidata.org/wiki/Q418384","display_name":"Fisetin","level":4,"score":0.8669337034225464},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7408917546272278},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.721835732460022},{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.6732996702194214},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.518219530582428},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.5019729137420654},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.49665647745132446},{"id":"https://openalex.org/C2779944601","wikidata":"https://www.wikidata.org/wiki/Q186969","display_name":"Ibuprofen","level":2,"score":0.49297070503234863},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.47877204418182373},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.444419264793396},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.42162787914276123},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.41841816902160645},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3141292333602905},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.21772775053977966},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19854435324668884},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.1966075599193573},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1768988072872162},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16732347011566162},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.07458129525184631},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.06829077005386353},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2779054382","wikidata":"https://www.wikidata.org/wiki/Q72185287","display_name":"Flavonoid","level":3,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.25.1_supplement.1004.7","doi":"https://doi.org/10.1096/fasebj.25.1_supplement.1004.7","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.25.1_supplement.1004.7","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3175361943","https://openalex.org/W1805634599","https://openalex.org/W46119268","https://openalex.org/W2018461735","https://openalex.org/W3035974263","https://openalex.org/W3167729363","https://openalex.org/W7124469335","https://openalex.org/W2953917005","https://openalex.org/W1977258406","https://openalex.org/W2775885880"],"abstract_inverted_index":{"Several":[0],"studies":[1],"mentioned":[2],"the":[3,15,33,36,53,56,132,159,167,188,207],"association":[4],"of":[5,22,38,59,102,134,151,161,169,209],"oxidative":[6],"stress":[7],"and":[8,42,48,64,89,127,171,177,190,199],"neuroinflammation":[9,210],"with":[10,99,118,212],"Parkinson's":[11],"disease":[12],"(PD).":[13],"In":[14],"MPTP\u2010injured":[16],"PC12":[17,95,147],"cells,":[18],"a":[19,121,128,155,174,183,203],"rat":[20],"model":[21],"PD,":[23],"MPTP":[24,115,145],"induces":[25],"cell":[26,125],"death":[27],"through":[28],"complex":[29],"I":[30],"inhibition":[31,160],"in":[32,66,108,124,131,144,158,173,186],"mitochondria,":[34],"increases":[35],"production":[37,168],"nitric":[39],"oxide":[40],"(NO)":[41],"pro\u2010inflammatory":[43],"mediators":[44],"such":[45],"as":[46],"IL\u20101beta":[47,76,172,191],"TNF\u2010alpha.":[49,135],"This":[50],"study,":[51],"investigated":[52],"mechanisms":[54],"underlying":[55],"neuroprotective":[57],"effect":[58,157,185],"two":[60],"anti\u2010inflammatory":[61],"drugs,":[62],"Fisetin":[63,164],"Ibuprofen":[65,136],"MPTP\u2010induced":[67],"PC12.":[68],"Cell":[69],"viability":[70],"was":[71,84],"measured":[72],"by":[73,80,86],"MTT":[74],"assay,":[75],"levels":[77,91],"were":[78,92,97],"quantified":[79],"ELISA,":[81],"TNF\u2010alpha":[82,142,162],"expression":[83,133,143],"assessed":[85],"western":[87],"blot,":[88],"NO":[90,170,189],"also":[93,140,165],"evaluated.":[94],"cells":[96],"pretreated":[98],"varying":[100],"doses":[101],"fisetin,":[103],"ibuprofen,":[104],"or":[105],"both":[106,152,179],"drugs":[107,153,180],"combination":[109,150],"for":[110,206],"2":[111,138],"hours,":[112],"prior":[113],"to":[114],"treatment.":[116],"Pretreatment":[117],"fisetin":[119,198],"produced":[120],"dose\u2010dependent":[122,129,175],"increase":[123],"viability,":[126],"decrease":[130],"at":[137],"\u03bcg/ml":[139],"decreased":[141],"treated":[146],"cells.":[148],"The":[149,193],"showed":[154,182],"synergistic":[156,184],"expression.":[163],"suppressed":[166],"manner,":[176],"that":[178,197],"combined":[181],"suppressing":[187],"production.":[192],"present":[194],"study":[195],"indicates":[196],"ibuprofen":[200],"may":[201],"provide":[202],"promising":[204],"approach":[205],"treatment":[208],"associated":[211],"PD.":[213]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}